Oncofetal ecosystems linked to recurrence and immunotherapy response in liver cancer

A team of clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS), Agency for Science, Technology and Research (A*STAR), the Harry Perkins Institute of Medical Research and global research partners, has found a causal link between the presence of oncofetal ecosystems (re-emergence of fetal programme/features driven by the tumor) in the primary liver cancer hepatocellular carcinoma (HCC) and cancer recurrence and response to immunotherapy.

Here’s How Common Long COVID Is in Children

Six to 12 months after COVID-19 infection, very few children developed post-COVID-19 conditions (PCCs) as defined by the World Health Organization (WHO), a prospective Canadian

December 30, 2023

Overcoming Financial Barriers to Diversity in Clinical Trials – Q/A

Meghan Harrington, VP of Clinical Trial Financial Management at Medidata Achieving diversity in clinical trials is crucial for developing effective and safe treatments for all

November 13, 2024

Medicare drug price negotiations

The list is mostly unsurprising but contains fewer cancer drugs than most industry experts had predicted. Credit: MargJohnsonVA via Shutterstock. The Biden Administration has released

October 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.